David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
PUT
J.M. Smucker
SJM
$13.3B
| $521K | ﹤0.01% |
5,000
| – | – |
|
|
DNKN
3327
PUT
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $521K | ﹤0.01% |
6,900
-3,100
| -31% | -$234K |
|
3328
Celanese
CE
$4.9B
| $520K | ﹤0.01% |
4,218
+1,204
| +40% | +$148K |
|
3329
NACCO Industries
NC
$311M
| $520K | ﹤0.01% |
11,110
+1,553
| +16% | +$82.4K |
|
3330
CALL
Impinj
PI
$5.02B
| $517K | ﹤0.01% |
20,000
| – | – |
|
|
PS
3331
PUT
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $516K | ﹤0.01% |
+30,000
| New | +$511K |
|
3332
Standard Motor Products
SMP
$835M
| $514K | ﹤0.01% |
9,658
-15,052
| -61% | -$768K |
|
|
GAP
3333
The Gap Inc
GAP
$7.25B
| $514K | ﹤0.01% |
29,100
-63,909
| -69% | -$1.09M |
|
|
SCWX
3334
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $512K | ﹤0.01% |
30,759
+15,235
| +98% | +$197K |
|
|
AHT
3335
Ashford Hospitality Trust
AHT
$21.6M
| $510K | ﹤0.01% |
+183
| New | +$512K |
|
3336
PUT
Akamai
AKAM
$15B
| $510K | ﹤0.01% |
5,900
-500
| -8% | -$43.7K |
|
3337
Franco-Nevada
FNV
$52.4B
| $510K | ﹤0.01% |
4,937
-203,402
| -98% | -$19.7M |
|
3338
PUT
Gen Digital
GEN
$17.4B
| $510K | ﹤0.01% |
20,000
| – | – |
|
3339
Okta
OKTA
$22.6B
| $509K | ﹤0.01% |
4,416
-43,209
| -91% | -$4.97M |
|
|
USAK
3340
DELISTED
USA Truck Inc
USAK
| $509K | ﹤0.01% |
68,340
-11,575
| -14% | -$87.7K |
|
|
WW
3341
PUT
DELISTED
WW International
WW
| $508K | ﹤0.01% |
13,300
-1,000
| -7% | -$37.9K |
|
3342
ProQR Therapeutics
PRQR
$323M
| $506K | ﹤0.01% |
+50,990
| New | +$397K |
|
3343
Sony
SONY
$140B
| $504K | ﹤0.01% |
+37,035
| New | +$462K |
|
3344
WEX
WEX
$6.84B
| $503K | ﹤0.01% |
+2,401
| New | +$481K |
|
3345
Albemarle
ALB
$15.7B
| $502K | ﹤0.01% |
6,875
-40,258
| -85% | -$2.69M |
|
3346
Elbit Systems
ESLT
$33.9B
| $501K | ﹤0.01% |
3,234
+399
| +14% | +$65K |
|
3347
Emcor
EME
$32.6B
| $500K | ﹤0.01% |
5,798
-2,007
| -26% | -$177K |
|
3348
PUT
FMC
FMC
$1.38B
| $499K | ﹤0.01% |
5,000
| – | – |
|
3349
Enanta Pharmaceuticals
ENTA
$416M
| $498K | ﹤0.01% |
8,068
-3,229
| -29% | -$200K |
|
3350
Star Bulk Carriers
SBLK
$3.48B
| $497K | ﹤0.01% |
+42,098
| New | +$455K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.